BeStock  
Stocks › Biotechnology › FTH

Faeth Therapeutics FTH

US equityMarket cap rank #3571Biotechnology
$24.92 −$1.97 (-7.33%)
Market closed · Oct 8, 7:00 am ET · Last extended-hours $24.92 0.00%
Open$26.71
Prev close$26.89
Day range$23.95 – $27.03
Volume322.6K
Market cap$643.94M
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

Technical signals

Trend readLeaning bearish

2 bullish · 5 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average-21.0%BearishTrading below the 20-day average of $31.56
Price vs 50-day average-21.4%BearishTrading below the 50-day average of $31.70
Price vs 200-day average+2.6%BullishTrading above the 200-day average of $24.28
50-day vs 200-day50d above 200dBullishThe 50-day average is above the 200-day average
RSI (14)31.7BearishMomentum leans negative
MACD (12,26,9)-1.94BearishMACD line is below its signal line
Bollinger band position11%BearishInside the 20-day bands

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$31.56-21.0%
50-day SMA$31.70-21.4%
200-day SMA$24.28+2.6%

Recent price levels

LevelPrice
20-day high$40.50
20-day low$23.95
60-day high$42.14
60-day low$23.12
Upper Bollinger band$40.17
Lower Bollinger band$22.95

The 50-day average is currently 30.6% above the 200-day average — consistent with a “golden cross” (bullish) configuration.

30-day volatility80.5%
Average true range9.63% of price
Max drawdown (1y)-69.2%
Volume (10d vs 90d)1.16x

Discussion

No comments yet — be the first to weigh in on FTH.

Leave a comment

Scroll to Top